Dating spravka ru
The surgeon talked about his development as future technology that will solve the problem with donor organs and change the idea of transplantation. All three of his patients whom he transplanted an invented organ at the Karolinska Institute clinic died.Macchiarini worked to create a bioengineered trachea. The government of the country allocated him a 150 million grant.Russian Science Foundation did not support the project of Paolo Macchiarini to create tissue-engineered constructs of the esophagus to replace the damaged organ with the models of the lower primates, which he leads.The list of the winning projects of the competition for extension of terms of projects by international research groups does not include the ambitious project of the Italian.Photo: The press service of the university could not answer where the Italian went.It is noteworthy that in January, Realnoe Vremya was promised to arrange a great interview with the scientist but only after an article on breakthrough discoveries in the field of transplantation and experiments on primates in the prestigious scientific journal would be published.After the story was publicized, the Swedish government dismissed the entire leadership of the Karolinska Institute, where Paolo Macchiarini worked.
As a medical journalist Alla Astakhova reported in her blog, only one patient survived.Note that a few countries have copyright terms longer than 70 years: Mexico has 100 years, Jamaica has 95 years, Colombia has 80 years, and Guatemala and Samoa have 75 years.This image may not be in the public domain in these countries, which moreover do not implement the rule of the shorter term.Russian Science Foundation has not renewed the 150-million grant for Macchiarini's project ''Creation of tissue-engineered constructs of the esophagus to replace the damaged organ with the model of non-human primates''.The KFU commented on the situation with the surgeon quite sparingly. Evil'', as he was dubbed for earlier unsuccessful experiments on humans, has left Kazan.